Options and Preferences for Treatments Informing recOmmendatioNS Study (OPTIONS Vasculitis) – Recruitment Closed
OPTIONS Lead Patient-Partner, Paul Brown
Hear Why Other Patients Are Participating
My name is Paul and like you, I am a patient with vasculitis involved in vasculitis research. I have been a member of the VPPRN since its launch in 2014 and have served as a patient partner in the governance of the VPPRN. I am currently the lead patient-partner for the OPTIONS study and I’m personally asking you to join in helping researchers and healthcare providers understand patient values and preferences about plasma exchange in ANCA associated vasculitis. About 15 minutes of your time to complete this survey will make a big impact, so join me today and participate in the OPTIONS study.
Goal of the Study
Who Can Participate?
What Is Involved?
WHAT SHOULD I KNOW ABOUT A RESEARCH STUDY?
- Whether or not you take part is up to you.
- You can choose not to take part.
- You can agree to take part and later change your mind.
- Your decision will not be held against you.
- You can ask all the questions you want before you decide.
Not a member of the VPPRN yet?
If you aren’t a member of the Vasculitis Patient-Powered Research Network (VPPRN), we invite you to join today!
We want to understand your individual patient experience. We will learn about individual patient experiences by collecting data you provide. We’ve made it easy for you to contribute this data to make vasculitis research happen now.
Interested in other research opportunities?
The goal of the VPPRN research program is to conduct high-quality studies that will improve the care and the health of patients with vasculitis by exploring research questions that matter most to patients and advance medical knowledge about vasculitis. Learn about current opportunities to participate in research.
Caz Cazanov: Becoming an Educated Patient Through VF ConferencesObviously, there’s never a “good” time to be diagnosed with vasculitis, but sometimes an onset happens with ironic impact at the worst possible time. In 2016, Caz Cazanov was looking forward to enjoying her new life after retiring from Kaiser Permanente, where she had spent 24 years working in health insurance legislative and regulatory policy. […]
Rituxan®, Corticosteroids Were Successful in Treating Patient with EGPA, Case Study Reports
Extraordinary Patient Videos
EGPA Extraordinary Patient VideosVF Extraordinary Patient Stories are a series of patient video interviews. Their stories will educate and inspire you.
Suzanne DePaolis – To the Friends Who Offer ‘Cures’ for My Chronic IllnessSometimes, a simple chat with my friends and family can turn into a conversation about me defending my health choices. People will insist on telling me ways to boost my immune system.